MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
181 Protein markers predict body composition during growth hormone (GH) treatment in short prepubertal children Clinical Endocrinology, March 11, 2013 Review Article
182 Low prevalence of metabolic syndrome and its prediction in Japanese inpatients with schizophrenia Human Psychopharmacology: Clinical and Experimental, March 11, 2013 Clinical Article
183 Co-existence of Chronic Urticaria and Metabolic Syndrome: Clinical Implications Acta Dermato-Venereologica, March 11, 2013 Review Article Clinical Article
184 Clinical and Genetic Risk Factors for Type 2 Diabetes at Early or Late Post Partum After Gestational Diabetes Mellitus Journal of Clinical Endocrinology and Metabolism, March 8, 2013 Clinical Article
185 Iron and Diabetes Risk Cell Metabolism, March 8, 2013 Clinical Article
186 Prospective Association of 25(OH)D with Metabolic Syndrome Clinical Endocrinology, March 8, 2013 Clinical Article
187 Islet inflammation: a unifying target for diabetes treatment? Trends in Endocrinology and Metabolism, March 8, 2013 Clinical Article
188 Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: Insights into the metabolic effects of growth hormone Growth Hormone & IGF Research, March 8, 2013 Review Article
189 Detecting and solving the interference of pregnancy serum, in a GH immunometric assay Growth Hormone & IGF Research, March 8, 2013 Review Article
190 Continuous glucose monitors: current status and future developments Current Opinion in Endocrinology, Diabetes and Obesity, March 7, 2013 Clinical Article
191 Metabolic Syndrome, ESRD, and Death in CKD Clinical Journal of the American Society of Nephrology, March 7, 2013 Clinical Article
192 Similarities and differences in cardiometabolic risk factors among remote Aboriginal Australian and Canadian cohorts Diabetes Research and Clinical Practice, March 7, 2013 Clinical Article
193 Clinical features and therapeutic outcomes of acromegaly during the recent 10 years in a single institution in Japan Pituitary, March 7, 2013 Review Article
194 Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes Acta Diabetologia, March 6, 2013 Clinical Article
195 Influence of Vitamin D Status on Vertebral Fractures, Bone Mineral Density, and Bone Turnover Markers in Normocalcemic Postmenopausal Women With High Parathyroid Hormone Levels Journal of Clinical Endocrinology and Metabolism, March 6, 2013 Clinical Article
196 Ethnic differences in beta-cell function, dietary intake and expression of the metabolic syndrome among UK adults of South Asian, black African-Caribbean and white-European origin at high risk of metabolic syndrome Diabetes & Vascular Disease Research, March 5, 2013 Review Article
197 The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis British Journal of Haematology, March 5, 2013 Clinical Article
198 Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators American Journal of Psychiatry, March 4, 2013 Evidence Based Medicine Review Article
199 The internal circadian clock increases hunger and appetite in the evening independent of food intake and other behaviors Obesity, March 4, 2013 Review Article
200 Impaired hypoxic cerebral vasodilation in younger adults with metabolic syndrome Diabetes & Vascular Disease Research, March 4, 2013 Review Article
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryAs reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryAnthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summary1 Challenging the Fructose Hypothesis: New Perspectives on Fructose Consumption and Metabolism Advances in Nutrition: An International Review Journal, April 3, 2013 Review Article
2 Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome Journal of Clinical Endocrinology and Metabolism, April 2, 2013 Evidence Based Medicine Clinical Guideline
3 Telmisartan as a metabolic sartan: The first meta-analysis of randomized controlled trials in metabolic syndrome Journal of the American Society of Hypertension, April 24, 2013
4 Glucocorticoid-Induced Hyperglycemia The American Journal of the Medical Sciences, April 11, 2013 Review Article
5 Characterizing Short Stature by Insulin-like Growth Factor Axis Status and Genetic Associations: Results From the Prospective, Cross-sectional, Epidemiogenetic EPIGROW Study Journal of Clinical Endocrinology and Metabolism, April 18, 2013
6 Long-term effects of recombinant human Growth Hormone (rhGH) replacement in adults with Growth Hormone Deficiency (GHD): a systematic review European Journal of Endocrinology, April 11, 2013 Evidence Based Medicine Review Article
7
High-sensitivity C-reactive protein and white blood cell count equally predict development of the metabolic syndrome in a Japanese health screening population
Acta Diabetologia, April 26, 2013
Review Article
Exclusive Author Commentary
8 The diagnostic criteria for gestational diabetes: to change or not to change? American Journal of Obstetrics and Gynecology, April 15, 2013
9 Adult growth hormone deficiency – benefits, side effects, and risks of growth hormone replacement Frontiers in Endocrinology, April 24, 2013 Review Article
10 Short-term outcome of patients with preeclampsia Vascular Health and Risk Management, April 25, 2013 Free full text
11 Guidelines Updates in the Treatment of Obesity or Metabolic Syndrome and Hypertension Current Hypertension Reports, April 2, 2013 Clinical Guideline
12 The role of human growth hormone's C-terminal disulfide bridge Growth Hormone & IGF Research, April 19, 2013 Review Article
13 Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria Hypertension Research, April 8, 2013
14 Migraine, headache and development of metabolic syndrome: An 11 year follow-up in the HUNT Study Pain, April 15, 2013
15 Intake of Whole-Grain and Fiber-Rich Rye Bread Versus Refined Wheat Bread Does Not Differentiate Intestinal Microbiota Composition in Finnish Adults with Metabolic Syndrome The Journal of Nutrition, April 1, 2013
16 Status of Cardiovascular Health in US Adolescents Circulation, April 10, 2013
17 Hepatic manifestations of metabolic syndrome Diabetes/Metabolism Research and Reviews, March 14, 2013 Review Article
18 Insulin Resistance of Protein Metabolism in Type 2 Diabetes and Impact on Dietary Needs: A Review Canadian Journal of Diabetes, April 29, 2013 Review Article
19 Study of Primary IGF-1 Deficiency in Egyptian Children with Idiopathic Short Stature Hormone Research in Paediatrics, April 26, 2013
20 Sleep Disordered Breathing as a Risk of Cardiac Events in Subjects With Diabetes Mellitus and Normal Exercise Echocardiographic Findings The American Journal of Cardiology, April 4, 2013
Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close